Stock Market Reviews

AGL (agilon health, inc.) News

Get the latest news, insights, and market updates on AGL (agilon health, inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Q3 Earnings Roundup: agilon health (NYSE:AGL) And The Rest Of The Outpatient & Specialty Care Segment
  Looking back on outpatient & specialty care stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including agilon health (NYSE:AGL) and its peers.
  Nov 18, 2025 - $AGL
• 1 Cash-Heavy Stock to Consider Right Now and 2 Facing Headwinds
  A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
  Nov 17, 2025 - $AGL
• agilon health to Participate in the 8th Annual Evercore Healthcare Conference
  WESTERVILLE, Ohio, November 12, 2025--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025 at 3:00pm ET.
  Nov 12, 2025 - $AGL
• 5 Insightful Analyst Questions From agilon health’s Q3 Earnings Call
  Agilon Health’s third quarter results showed revenue above Wall Street expectations, but profitability remained pressured due to persistent headwinds. Management attributed the quarter’s performance to ongoing execution of clinical and quality programs and cost discipline, but also highlighted the negative impact from lower-than-expected risk adjustment scores and elevated costs from exited markets. Executive Chairman Ronald Williams noted, “We were impacted by lower-than-expected in-year RAF co
  Nov 11, 2025 - $AGL
• Why agilon health (AGL) Shares Are Getting Obliterated Today
  Shares of healthcare services company Agilon Health (NYSE:AGL) fell 6.8% in the afternoon session after the company received a non-compliance notice from the New York Stock Exchange because its stock price fell below listing standards.
  Nov 7, 2025 - $AGL
• Analysts Have Been Trimming Their agilon health, inc. (NYSE:AGL) Price Target After Its Latest Report
  It's been a mediocre week for agilon health, inc. ( NYSE:AGL ) shareholders, with the stock dropping 13% to US$0.70 in...
  Nov 7, 2025 - $AGL
• agilon Announces Receipt of Notice of Non-Compliance with the NYSE Continued Listing Standards
  WESTERVILLE, Ohio, November 07, 2025--agilon health, inc. (the "Company") (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that the New York Stock Exchange (the "NYSE") issued a notice (the "Notice") on November 5, 2025 informing the Company that it is no longer in compliance with its continued listing standards because the average closing price of the Company’s common stock was less than $1.00 per share over a consecutive 30 tra
  Nov 7, 2025 - $AGL
• agilon health (AGL) Revenue Growth Outpaces Market but Losses Deepen, Testing Bull Narratives
  agilon health (AGL) turned in another unprofitable stretch, with losses accelerating at an average annual rate of 7.9% over the last five years and net profit margins showing no signs of improvement. While the company is forecast to remain in the red through at least the next three years, revenue is expected to grow 10.62% per year, edging out the broader US market's 10.5% annual growth rate. Value investors may be drawn to AGL’s discounted share price and notably low 0.1x price-to-sales...
  Nov 6, 2025 - $AGL
• Here's What Key Metrics Tell Us About Agilon (AGL) Q3 Earnings
  The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
  Nov 5, 2025 - $AGL
• AGL Q3 Deep Dive: Revenue Beats Expectations Amid Profitability Challenges and Strategic Realignment
  Healthcare services company Agilon Health (NYSE:AGL) announced better-than-expected revenue in Q3 CY2025, but sales fell by 1.1% year on year to $1.44 billion. The company expects the full year’s revenue to be around $5.82 billion, close to analysts’ estimates. Its GAAP loss of $0.27 per share was 60% below analysts’ consensus estimates.
  Nov 5, 2025 - $AGL